Pharvaris N.V. (PHVS)
NASDAQ: PHVS · Real-Time Price · USD
28.81
-1.59 (-5.23%)
May 18, 2026, 4:00 PM EDT - Market closed
Pharvaris Market Cap
Pharvaris has a market cap or net worth of $1.88 billion as of May 19, 2026. Its market cap has increased by 88.24% in one year.
Market Cap
1.88B
Enterprise Value
1.60B
1-Year Change
88.24%
Ranking
Category
Stock Price
$28.81
Market Cap Chart
Since the IPO on February 5, 2021, Pharvaris's market cap has increased from $636.80M to $1.88B, an increase of 195.92%. That is a compound annual growth rate of 22.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 1.88B | 4.33% |
| Dec 31, 2025 | 1.80B | 73.39% |
| Dec 31, 2024 | 1.04B | -28.87% |
| Dec 29, 2023 | 1.46B | 284.53% |
| Dec 30, 2022 | 380.11M | -20.27% |
| Dec 31, 2021 | 476.72M | -25.14% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ADMA Biologics | 1.94B |
| Trevi Therapeutics | 1.91B |
| Mesoblast | 1.89B |
| Ocular Therapeutix | 1.83B |
| Stoke Therapeutics | 1.81B |
| Sarepta Therapeutics | 1.80B |
| Zymeworks | 1.78B |
| Vericel | 1.78B |